1. 11P Association of VISTA-expressing CD66b-positive neutrophils, with response and survival benefit from pembrolizumab in advanced malignant pleural mesothelioma. (December 2022) Authors: Homicsko, K.; Zygoura, P.; Tissot, S.; Norkin, M.; Popat, S.; Curioni-Fontecedro, A.; O'Brien, M.E.R.; Pope, T.; Shah, R.; Kammler, R.; Finn, S.P.; Coukos, G.; Dafni, U.; Peters, S.; Stahel, R.A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 194P Thermal ablation followed by intratumoral injection of a novel immune stimulant IP-001 in patients with advanced solid tumors: Phase IB part of study SAKK 66/17. (December 2022) Authors: Joerger, M.; Knüsel, P.; Alejandre-Lafont, E.; Metaxas, Y.; Mark, M.T.; von Moos, R.A.F.; Gysel, K.; Eckhardt, K.; Glaus Garzon, J.; Koster, K-L.; Wittwer, Y.; Tissot, S.; Flatz, L.; Alleruzzo, L.; Lam, S.K.; Anderson, D.; Chen, W.; Baskin-Bey, E.; Hode, T. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 42P Tumor-reactive CD8+ T cells in ovarian and colon cancer in tumors and cell products. (December 2022) Authors: Bobisse, S.; Navarro Rodrigo, B.; Ngo, Q-A.; Chiffelle, J.; Genolet, R.; Michel, A.; Saugy, D.; Sauvage, C.; Tarussio, D.; Arnaud, M.; Guillaume, P.; Stevenson, B.; Bassani-Sternberg, M.; Tissot, S.; Rusakiewicz, S.; Schmidt, J.; Dangaj, D.; Kandalaft, L.; Coukos, G.; Harari, A. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗